Hollister Biosciences Inc Reports Q2 2021 Financial Results including USD $17 6 million revenue, and USD $3 2 million of Adjusted EBITDA
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Hollister Biosciences Inc Reports Q2 2021 Financial Results including USD $17 6 million revenue, and USD $3 2 million of Adjusted EBITDA
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
First quarter revenue was USD $23.1 million compared to USD $0.95 million in the first quarter of 2020 and up 97% sequentially from USD $11.7 million in the fourth quarter of 2020
First quarter net income was USD $2.0 million compared to a net loss of USD $2.2 million in the first quarter of 2020
Adjusted EBITDA was USD $2.80 million in the first quarter compared to a loss of USD $1.1 million in the first quarter of 2020
VANCOUVER, BC, June 1, 2021 /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the
Company ,
Hollister Cannabis Co. or
Hollister ) a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 95 dispensaries throughout Arizona, today reported its financial and operating results for the first quarter of 2021. All financial information is presented in U.S. dollars unless otherwise indicated.
Share this article
Total revenue in 2020 was USD $30.6 million compared to USD $1.0 million in 2019
Fourth quarter revenue was USD $11.7 million compared to USD $0.35 million in the fourth quarter of 2019
Net loss for the full year was USD $3.7 million compared to a net loss of USD $1.9 million in 2019
Net loss in the fourth quarter was USD $1.1 million compared to a net loss of USD $1.33 million in the fourth quarter of 2019
VANCOUVER, BC, May 31, 2021 /PRNewswire/ - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the
Company ,
Hollister Cannabis Co. or
Hollister ) a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 95 dispensaries throughout Arizona, today reported its financial and operating results for the fourth quarter and year ended 2020. All financial information is presented in U.S. dollars unless otherwise indicated.